First described in 2009 in Japan, the emerging multidrug-resistant fungal pathogen Candida
auris is becoming a worldwide public health threat that has been attracting considerable …

summary A paradigm shift of candidiasis from Candida albicans to non‐albicans Candida
species has fundamentally increased with the advent of C. auris. C. auris, despite being a …

During this report, the synthesis, characterization, medicinal, and molecular modeling of
newly synthesized, bidentate sulfonamide metal (VO 2+, Co 2+, Ni 2+, Cu 2+, and Zn 2+) …

Candida auris has unprecedently emerged as a multidrug resistant fungal pathogen,
considered a serious global threat due to its potential to cause nosocomial outbreaks and …

The enigmatic yeast Candida auris has emerged over the last decade and rapidly
penetrated our consciousness. The global threat from this multidrug-resistant yeast has …

Candida auris is a novel and major fungal pathogen that has triggered several outbreaks in
the last decade. The few drugs available to treat fungal diseases, the fact that this yeast has …

Candida auris is an emerging fungal pathogen that exhibits resistance to multiple drugs,
including the most commonly prescribed antifungal, fluconazole. Here, we use a …

Candida auris is an emerging, multi drug resistant fungal pathogen that has caused
infectious outbreaks in over 45 countries since its first isolation over a decade ago, leading …

Fungal infections impact the lives of at least 12 million people every year, killing over 1.5
million. Wide-spread use of fungicides and prophylactic antifungal therapy have driven …

Antimicrobial resistance (AMR) occurs when microbes no longer respond to any
pharmacological agents, rendering the conventional antimicrobial agents ineffective. AMR …